Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
| Status: | Completed |
|---|---|
| Conditions: | High Blood Pressure (Hypertension), Ocular |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Ophthalmology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 2/4/2013 |
| Start Date: | September 2011 |
| End Date: | November 2012 |
| Contact: | Jeff Gregory, MD |
| Email: | jgregory@acucela.com |
An Investigator-Masked, Dose-Escalation Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
This is a study of the safety, tolerability, pharmacokinetics (measurement of drug levels in
the blood), and intraocular pressure lowering effects of OPA-6566 ophthalmic solution in
subjects with primary open-angle glaucoma or ocular hypertension.
Inclusion Criteria:
- diagnosis of bilateral primary open-angle glaucoma
- diagnosis of ocular hypertension as defined in the protocol
Exclusion Criteria:
- any form of glaucoma other than primary open-angle glaucoma in either eye
- other ocular conditions as defined by the protocol
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials